# CellBion Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellbion-co

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Website: www.cellbion.co.kr
- Total disclosed funding: $12M
- Latest round: Series C (Dec 22, 2017)
- Investors on record: 8

## About

Founded in 2010 and based in Seoul, South Korea, CellBion Co., Ltd., operates as a biopharmaceutical company that specializes in the development of radiopharmaceuticals and radioligand therapies that target cancer in patients. In October 2023, CellBion Co., Ltd. raised KRW 8 billion in pre-IPO funding from Harang Invest, Huons, and Sinsin Pharm, with participation from returning investor Hana Ventures. As of 2023, the company is led by its CEO, Kweon Kim.

The company offers radiopharmaceuticals and medical imaging systems associated with lower side effects, attributed to the very short hydrophilic linker that allows quick excretion through the kidneys, reducing side effects.

The company uses medical imaging techniques, including mPERCIST and RECIST, to assess the response to treatment.

The company plans to use the October 2023 funding to finalize clinical trials and prepare for listing on the KOSDAQ market.

## Funding rounds

- Series C, Dec 22, 2017, $5.3M — Samho Green Investment, ST Capital
- Series B, Dec 16, 2016, $4.7M — Korea Development Bank, Mirae Asset Capital
- Series A, Sep 19, 2015, $0.4M — SU&P, Dong-Yu Technology Investment
- Series A, Jul 1, 2015, $0.4M — ID Ventures
- Series A, May 22, 2015, $1.1M — HB Investment

## Investors

- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series A
- ID Ventures (https://capitalatlas.ai/funds/id-ventures) — Series A
- SU&P (https://capitalatlas.ai/funds/su-p) — Series A
- Dong-Yu Technology Investment (https://capitalatlas.ai/funds/dong-yu-technology-investment) — Series A
- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series B
- Mirae Asset Capital (https://capitalatlas.ai/funds/mirae-asset-capital) — Series B
- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series C
- ST Capital (https://capitalatlas.ai/funds/st-capital) — Series C